Introduction

35
The oxazolidinone antibiotic linezolid has been available since 2000 as a therapeutic 36 alternative against antibiotic resistant Gram-positive cocci. It inhibits bacterial protein 37 synthesis through binding in the A site pocket at the peptidyltransferase centre, domain V of 38 the 23S ribosomal RNA of the 50S subunit [1] . Recently the first human isolate of 39 Enterococcus faecalis with transferable linezolid resistance encoded by the cfr 40 (chloramphenicol-florfenicol resistance) gene was recovered from a patient in Thailand [2] .
41
The cfr gene encodes a methyltransferase which has previously been reported to methylate faecium (LR-VSEfm) (isolate 1), and he was treated with vancomycin. On hospital day 24 101 laparoscopic drainage of the peritoneum was performed and two days later he was moved to 102 ward C at his local hospital 2. The patient died some months later from his cancer.
103
A 61-y-old woman (patient 2) with inoperable metastatic cancer of the pancreas and [29] . In line with these reports, the ST117 high-risk clone described in the present study 168 was apparently able to cause bacteraemia in the first two cancer patients and then survived in 169 the hospital environment for more than a year before being isolated from the urethral catheter 170 of the third patient. 
